...
Full 2
XINBELL
Trusted Partner for Your API Needs: Quality, Reliability, and Innovation
Full 2
Full 2
XINBELL
Transforming Chemicals into Solutions: Innovative Intermediates for Your Industry
Full 2
Full 2
XINBELL
Your Partner for Customized Fine Chemical Solutions: Trust, Quality, and Expertise
Full 2
previous arrow
next arrow

About Us

Nanjing Xinbell Pharmaceutical Technology Co., Ltd. was established in October 2014. It is located in Nanjing, Jiangsu Province, in the Yangtze River Delta Region. Xinbell is a professional company specializing in developing, producing and marketing of pharmaceutical intermediates.

The company’s products are mainly involved in the field of anti-tumor, epilepsy, rheumatism, cardiovascular and cerebrovascular and have been sold to more than ten countries, such as Europe, India, Japan, South Korea and Southeast Asia. At the present, the company cooperates with three GMP complied factories and two domestic university and R & D center.

The 85th API China & 24th China Pharm opens

October 14, 2020, The 85th China International Pharmaceutical Equipment Exhibition (API China) and the 24th China International (industry) exhibition & Technology Exchange Conference (China-Pharm) opened …

Xinbell participated in CPhI & P-MEC China 2019

June 18-20, 2019, The 19th International Convention on Pharmaceutical Ingredients and Intermediates China opened in Shanghai. Many well-known pharmaceutical enterprises from all over the world …

Modified new drugs approved by FDA in October 2022

Approval Date Drug Name Application Number Active Ingredient Submit Type Company Name 2022-10-3 ALVAIZ NDA 216774 ELTROMBOPAG CHOLINE New active ingredients TEVA PHARMS 2022-10-6 NOREPINEPHRINE …

Work with us to get the best quality medicine.
Nanjing XinBell Pharmaceutical Technology Co., Ltd.

Enquiry